Acology Inc (OTCMKTS:ACOL) Shares Launch on Positive Medtainer Demand Growth

Acology Inc (OTCMKTS:ACOL) Shares Launch on Positive Medtainer Demand Growth

SHARE

One stock that has recently exploded higher is Acology Inc (OTCMKTS:ACOL). This is the latest explosion on the OTC. The move comes in response to a press release pointing to accelerating traction in its Medtainer segment. Shares are up over 100% already this week on the news.

Most significantly, the company just announced that Aurora Cannabis (OTCMRKTS:ACBFF) has placed its’ 7th order for thousands of MedTainers in anticipation of the mid-October start to Canada’s legal recreational cannabis market. According to the release, “The company states that it anticipated and is well-prepared to fulfill the increased influx of orders for their signature multi-functional, certified child-resistant, FDA-approved container.”

Acology Inc (OTCMKTS:ACOL) designs, manufactures, brands, and sells proprietary plastic medical grade containers in the United States. The company offers Medtainer containers that store pharmaceuticals, herbs and herbal remedies, teas, and other solids or liquids, as well as coffee, wines and liquors, and food products. It also provides private labeling and branding services for purchasers of containers and other products.

In addition, the company sells and distributes humidity control inserts, lighters, smell?proof bags, hydroponic grow towers, and other items. It markets its products directly to end users; and retail public through Internet, as well as wholesalers and other businesses. The company was incorporated in 1997 and is based in Corona, California.

Acology Containers give consumers the ability to store, carry, and dispense items such as pharmaceuticals, herbal remedies, teas and many other solid and/or liquid contents with ease.

According to company materials, “Acology/MedTainer has set its’ sights on strategic partnerships with several of these emerging companies and will possibly have agreements in place by the end of the year. Acology/Medtainer’s management’s design is to offer numerous size and functionality options for the entire cannabis industry. The 20-dram Medtainer will become the platform to launch these packaging selections with the goal of capturing 5% of the total global cannabis packaging market by 2022. North America is an essential part of the organizational blueprint, with the eventual reclassification of the United States FDA cannabis Schedule 1 designation happening, as some experts have predicted, next year.”

Find out when $ACOL stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

As noted above, the company just announced some major expansion in demand for its Medtainers, including some big orders from Aurora Cannabis. In all, traders will note a bit less than 140% added to share values of the listing over the past week of action, but this action is running counter to the larger trend in the name. Furthermore, the name has registered increased average transaction volume recently, with the past month seeing approaching 880% over the long run average.

According to its latest release, “The company also introduced a new size 40-dram MedTainer to the market, doubling the size of its’ signature product. This is in keeping with the anticipated demand of consumers who will want larger quantities of retail flower cannabis and make it easier to classify and label retail cannabis, as demanded by Canadian federal law.”

MedTainer Inc. reportedly feels that these events signal a continuation of its growth in the Canadian market. The company apparently predicted this growth last year and continuing this year once the Canadian Legislature approved cannabis for legal recreational use. “MedTainer Inc. continues to see a steady expansion in North America and anticipates that with the offer of multiple-sized, multiple-function containers this trend will continue. MedTainer Inc. anticipates doubling its’ sales and profits in 2019.”

Earning a current market cap value of $112.29M, ACOL has virtually no cash on the books, which is balanced by about $1.1M in total current liabilities. ACOL is pulling in trailing 12-month revenues of $2.3M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 1.3%. We will update the story again soon as developments transpire. Sign-up for continuing coverage on shares of $ACOL stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $ACOL, either long or short, and we have not been compensated for this article.

Sign Up for our 100% FREE Oracle Dispatch Newsletter